GB9923445D0 - Novel process - Google Patents
Novel processInfo
- Publication number
- GB9923445D0 GB9923445D0 GBGB9923445.2A GB9923445A GB9923445D0 GB 9923445 D0 GB9923445 D0 GB 9923445D0 GB 9923445 A GB9923445 A GB 9923445A GB 9923445 D0 GB9923445 D0 GB 9923445D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel process
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9923445.2A GB9923445D0 (en) | 1999-10-04 | 1999-10-04 | Novel process |
AU75422/00A AU7542200A (en) | 1999-10-04 | 2000-10-04 | Process for the preparation of paroxetine hydrochloride acetone solvate |
PCT/GB2000/003795 WO2001025230A1 (en) | 1999-10-04 | 2000-10-04 | Process for the preparation of paroxetine hydrochloride acetone solvate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9923445.2A GB9923445D0 (en) | 1999-10-04 | 1999-10-04 | Novel process |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9923445D0 true GB9923445D0 (en) | 1999-12-08 |
Family
ID=10862098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9923445.2A Ceased GB9923445D0 (en) | 1999-10-04 | 1999-10-04 | Novel process |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU7542200A (en) |
GB (1) | GB9923445D0 (en) |
WO (1) | WO2001025230A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR001982A1 (en) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION |
GB9826178D0 (en) * | 1998-11-30 | 1999-01-20 | Smithkline Beecham Plc | Novel process |
-
1999
- 1999-10-04 GB GBGB9923445.2A patent/GB9923445D0/en not_active Ceased
-
2000
- 2000-10-04 WO PCT/GB2000/003795 patent/WO2001025230A1/en active Application Filing
- 2000-10-04 AU AU75422/00A patent/AU7542200A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU7542200A (en) | 2001-05-10 |
WO2001025230A1 (en) | 2001-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9917851D0 (en) | Process | |
GB9905512D0 (en) | Process | |
GB9920917D0 (en) | Novel process | |
GB9908814D0 (en) | Process | |
GB9924882D0 (en) | Novel process | |
GB9914209D0 (en) | Process | |
GB9914583D0 (en) | Novel process | |
GB9904162D0 (en) | Process | |
GB9930577D0 (en) | Novel process | |
GB9926908D0 (en) | Novel process | |
GB9916392D0 (en) | Novel process | |
GB9905418D0 (en) | Process | |
GB9920147D0 (en) | Novel process | |
GB9916187D0 (en) | Novel process | |
GB9917330D0 (en) | Process | |
GB9903087D0 (en) | Process | |
GB9915303D0 (en) | Novel process | |
GB9920146D0 (en) | Novel process | |
GB9919001D0 (en) | Novel process | |
GB9921243D0 (en) | Novel process | |
GB9923539D0 (en) | Novel process | |
GB9909973D0 (en) | Process | |
GB9923540D0 (en) | Novel process | |
GB9914046D0 (en) | Novel process | |
GB9923439D0 (en) | Novel process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |